Patents by Inventor Kerstin Rebrin
Kerstin Rebrin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220047194Abstract: Method and device for outputting one or more signals associated with a monitored analyte level of an individual, the one or more signals including a substantially real time monitored analyte level and a rate of change information associated with the monitored analyte level, outputting a carbohydrate intake event indication, determining one or more data associated with one or more therapy information related to the monitored analyte level and the meal event indication, and outputting the determined one or more data over the outputted one or more signals associated with the monitored analyte level and the carbohydrate intake event indication are provided.Type: ApplicationFiled: November 1, 2021Publication date: February 17, 2022Inventors: Thomas A. PEYSER, Marc B. TAUB, R. Curtis JENNEWINE, Timothy Christian DUNN, Kerstin REBRIN
-
Patent number: 11166654Abstract: Method and device for outputting one or more signals associated with a monitored analyte level of an individual, the one or more signals including a substantially real time monitored analyte level and a rate of change information associated with the monitored analyte level, outputting a carbohydrate intake event indication, determining one or more data associated with one or more therapy information related to the monitored analyte level and the meal event indication, and outputting the determined one or more data over the outputted one or more signals associated with the monitored analyte level and the carbohydrate intake event indication are provided.Type: GrantFiled: August 30, 2018Date of Patent: November 9, 2021Assignee: ABBOTT DIABETES CARE INC.Inventors: Thomas A. Peyser, Marc B. Taub, R. Curtis Jennewine, Timothy Christian Dunn, Kerstin Rebrin
-
Publication number: 20190008433Abstract: Method and device for outputting one or more signals associated with a monitored analyte level of an individual, the one or more signals including a substantially real time monitored analyte level and a rate of change information associated with the monitored analyte level, outputting a carbohydrate intake event indication, determining one or more data associated with one or more therapy information related to the monitored analyte level and the meal event indication, and outputting the determined one or more data over the outputted one or more signals associated with the monitored analyte level and the carbohydrate intake event indication are provided.Type: ApplicationFiled: August 30, 2018Publication date: January 10, 2019Applicant: Abbott Diabetes Care Inc.Inventors: Thomas A. Peyser, Marc B. Taub, R. Curtis Jennewine, Timothy Christian Dunn, Kerstin Rebrin
-
Patent number: 10080529Abstract: Apparatuses and methods for medical monitoring physiological characteristics values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide dynamic glucose monitoring functions that perform predictive analysis to anticipate harmful conditions, such as glucose crash and hyperglycemic incidents for a patient. The dynamic functions can also be used to maximize athletic performance and warn of inadequate nocturnal basal rate. Other aspects include advanced alarm and reminder functions, as well as advanced data presentation tools to further facilitate convenient and efficient management of various physiological conditions.Type: GrantFiled: January 16, 2015Date of Patent: September 25, 2018Assignee: Medtronic MiniMed, Inc.Inventors: James Kelly Fox, Garry M. Steil, Kerstin Rebrin, Mark C. Estes, Frank Saidara
-
Publication number: 20150374271Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.Type: ApplicationFiled: September 4, 2015Publication date: December 31, 2015Inventors: Geoffrey V. McGarraugh, Benjamin J. Feldman, Thomas A. Peyser, John C. Mazza, Timothy T. Goodnow, Kerstin Rebrin
-
Publication number: 20150190100Abstract: Apparatuses and methods for medical monitoring physiological characteristics values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide dynamic glucose monitoring functions that perform predictive analysis to anticipate harmful conditions, such as glucose crash and hyperglycemic incidents for a patient. The dynamic functions can also be used to maximize athletic performance and warn of inadequate nocturnal basal rate. Other aspects include advanced alarm and reminder functions, as well as advanced data presentation tools to further facilitate convenient and efficient management of various physiological conditions.Type: ApplicationFiled: January 16, 2015Publication date: July 9, 2015Inventors: James Kelly Fox, Garry M. Steil, Kerstin Rebrin, Mark C. Estes, Frank Saidara
-
Patent number: 7920907Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.Type: GrantFiled: June 7, 2007Date of Patent: April 5, 2011Assignee: Abbott Diabetes Care Inc.Inventors: Geoffrey V. McGarraugh, Benjamin J. Feldman, Thomas A. Peyser, John C. Mazza, Timothy T. Goodnow, Kerstin Rebrin
-
Patent number: 7766830Abstract: Apparatuses and methods for medical monitoring physiological characteristics values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide dynamic glucose monitoring functions that perform predictive analysis to anticipate harmful conditions, such as glucose crash and hyperglycemic incidents for a patient. The dynamic functions can also be used to maximize athletic performance and warn of inadequate nocturnal basal rate. Other aspects include advanced alarm and reminder functions, as well as advanced data presentation tools to further facilitate convenient and efficient management of various physiological conditions.Type: GrantFiled: November 30, 2004Date of Patent: August 3, 2010Assignee: Medtronic MiniMed, Inc.Inventors: James Kelly Fox, Garry M. Steil, Kerstin Rebrin, Mark C. Estes, Frank Saidara
-
Publication number: 20090281406Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.Type: ApplicationFiled: July 20, 2009Publication date: November 12, 2009Applicant: Abbott Diabetes Care Inc.Inventors: Geoffrey V. McGarraugh, Benjamin J. Feldman, Thomas A. Peyser, John C. Mazza, Timothy T. Goodnow, Kerstin Rebrin
-
Publication number: 20090143725Abstract: Method and device for outputting one or more signals associated with a monitored analyte level of an individual, the one or more signals including a substantially real time monitored analyte level and a rate of change information associated with the monitored analyte level, outputting a carbohydrate intake event indication, determining one or more data associated with one or more therapy information related to the monitored analyte level and the meal event indication, and outputting the determined one or more data over the outputted one or more signals associated with the monitored analyte level and the carbohydrate intake event indication are provided.Type: ApplicationFiled: August 28, 2008Publication date: June 4, 2009Applicant: Abbott Diabetes Care, Inc.Inventors: Thomas A. Peyser, Marc B. Taub, R. Curtis Jennewine, Timothy Christian Dunn, Kerstin Rebrin
-
Publication number: 20080188796Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.Type: ApplicationFiled: April 4, 2008Publication date: August 7, 2008Applicant: MEDTRONIC MINIMED, INC.Inventors: Garry M. Steil, Kerstin Rebrin
-
Patent number: 7402153Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.Type: GrantFiled: March 31, 2004Date of Patent: July 22, 2008Assignee: Medtronic MiniMed, Inc.Inventors: Garry M. Steil, Kerstin Rebrin
-
Patent number: 7354420Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.Type: GrantFiled: May 3, 2006Date of Patent: April 8, 2008Assignee: Medtronic MiniMed, Inc.Inventors: Garry M. Steil, Kerstin Rebrin
-
Publication number: 20080071158Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.Type: ApplicationFiled: June 7, 2007Publication date: March 20, 2008Applicant: Abbott Diabetes Care, Inc.Inventors: Geoffrey McGarraugh, Benjamin Feldman, Thomas Peyser, John Mazza, Timothy Goodnow, Kerstin Rebrin
-
Publication number: 20080071157Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.Type: ApplicationFiled: June 7, 2007Publication date: March 20, 2008Applicant: Abbott Diabetes Care, Inc.Inventors: Geoffrey McGarraugh, Benjamin Feldman, Thomas Peyser, John Mazza, Timothy Goodnow, Kerstin Rebrin
-
Publication number: 20080064937Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.Type: ApplicationFiled: June 7, 2007Publication date: March 13, 2008Applicant: Abbott Diabetes Care, Inc.Inventors: Geoffrey McGarraugh, Benjamin Feldman, Thomas Peyser, John Mazza, Timothy Goodnow, Kerstin Rebrin
-
Publication number: 20080058625Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.Type: ApplicationFiled: June 7, 2007Publication date: March 6, 2008Applicant: Abbott Diabetes Care, Inc.Inventors: Geoffrey McGarraugh, Benjamin Feldman, Thomas Peyser, John Mazza, Timothy Goodnow, Kerstin Rebrin
-
Patent number: 7267665Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.Type: GrantFiled: December 31, 2002Date of Patent: September 11, 2007Assignee: Medtronic MiniMed, Inc.Inventors: Garry M. Steil, Kerstin Rebrin
-
Publication number: 20060224109Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.Type: ApplicationFiled: May 3, 2006Publication date: October 5, 2006Inventors: Garry Steil, Kerstin Rebrin
-
Patent number: 7022072Abstract: Apparatuses and methods for medical monitoring physiological characteristics values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide dynamic glucose monitoring functions that perform predictive analysis to anticipate harmful conditions, such as glucose crash and hyperglycemic incidents for a patient. The dynamic functions can also be used to maximize athletic performance and warn of inadequate nocturnal basal rate. Other aspects include advanced alarm and reminder functions, as well as advanced data presentation tools to further facilitate convenient and efficient management of various physiological conditions.Type: GrantFiled: December 27, 2001Date of Patent: April 4, 2006Assignee: Medtronic MiniMed, Inc.Inventors: James Kelly Fox, Garry M. Steil, Kerstin Rebrin, Mark C. Estes, Frank Saidara